Tristan Hasbargen, PA-C, a physician assistant at Dermatology Associates of Tallahassee in Tallahassee, Florida, discusses the treatment of vitiligo, emphasizing the importance of setting patient
David Rosmarin, MD, the chair of the Department of Dermatology at Indiana University in Indianapolis, discusses results from a pooled subgroup analysis of the 104-week
Ted Lain, MD, MBA, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, discusses the randomized phase 3 THRIVE-AA1 trial (NCT04518995), which assessed the safety
Christopher Bunick, MD, PhD, an associate professor of dermatology at Yale School of Medicine in New Haven, Connecticut, discusses a poster presentation comparing the itch
Leon Kircik, MD, a board-certified dermatologist at the Icahn School of Medicine at Mount Sinai in New York, New York, discusses the history of isotretinoin
David Cotter, MD, PhD, a board-certified dermatologist at Las Vegas Dermatology in Las Vegas, Nevada, discusses a patient case of prurigo nodularis and related trial
Kara Mudd reviews findings from the Phase 3 TRuE-AD3 study evaluating topical ruxolitinib in children aged 2 to <12 years with atopic dermatitis. The discussion
Dr. Hilary Baldwin, the director of the Acne Treatment and Research Center in Brooklyn, New York, discusses a low-dose formulation of isotretinoin designed for better
Dr. Farberg explores the evolving treatment landscape for alopecia areata, with a focus on JAK inhibitors and their role in selectively targeting immune pathways involved
Dr. Shahriari reviews the FDA’s decision to remove certain “black box” warnings for hormone replacement therapy (HRT) and discusses how this shift may influence treatment
Dr. Graber explores how micronized formulations can improve drug absorption in acne therapy. She explains how enhanced absorption may support more consistent treatment outcomes and
Dr. Murase discusses the symptoms and presentation of prurigo nodularis and highlights recent research that demonstrates the effectiveness of nemolizumab for treating patients with this
Dr. Mirmirani examines the current treatment landscape for extensive and severe alopecia areata, focusing on longstanding unmet needs and how recent FDA-approved therapies are beginning
Drs. Del Rosso and Cotter discuss advances in the molecular understanding of prurigo nodularis, which have enabled the development of targeted pharmaceuticals that treat the
Dr. Lain discusses clinical research that assessed the use of a Hydro Boost regimen alongside energy- and non-energy-based device treatments.
Dr. Nguyen discusses the complexities involved in treating chronic hand eczema (CHE), emphasizing how overlapping etiologies can make diagnosis and long-term management challenging. His presentation
Dr. Chovatiya discusses evolving treatment strategies for Generalized Pustular Psoriasis (GPP) and how recent clinical research is reshaping the management paradigm for this severe inflammatory
Dr. Moody discusses a poster presented at the 2025 Fall Clinical Dermatology Conference that evaluated the 31-GEP test across all melanoma subtypes. Reference: Marks E
Dr. Mostaghimi reviews pivotal data from the Phase 3 THRIVE-AA1 and THRIVE-AA2 clinical trials, which evaluated the safety and efficacy of deuruxolitinib in patients with
Dr. Rizzo discusses how the 31-GEP test can inform routine imaging guidance and provides improved risk stratification in patients with melanoma. References: Dhillon S, Duarte-Bateman
Dr. Desai discusses treating patients with vitiligo with ruxolitinib cream 1.5% in the face and neck area.
Chantel Hillestad discusses treatment options for vitiligo on the hands and how UV exposure can increase the presentation of vitiligo.
Dr. Qureshi discusses his session about providing effective treatment for lupus and dermatomiasitis.
Drs. Harper and Baldwin discuss treating patients with acne and rosacea, as well as the impact isotretinoin can have on hormonal birth control.
Dr. Husni discusses managing care for patients with psoriatic diseases.
Dr. Fallon-Friedlander discusses a case of an adolescent who presented with cognitive decline, forgetfulness, and seizures and was eventually diagnosed with subacute sclerosing panencephalitis.
Dr. Seiverling discusses the overlapping clinical features of atypical nevi and melanoma, as well as the diagnostic challenges this causes.
Kara Mudd discusses treating difficult cases in contact dermatitis and the extra steps needed to help patients avoid allergens.
Dr. Fallon-Friedlander discusses common challenges in pediatric patients with skin conditions such as melanoma, wounds, and eczema.
Stephanie DePouw-Simmerman discusses her session that reviewed updates in treatment for patients with psoriasis.
Melissa Davis discusses a challenging case of a patient with neuritic leprosy.
Dr. Cotton discusses providing effective treatment for pediatric patients in dermatology.
Dr. Liszewski discusses treatment pearls for patients with dermatoses such as lichen sclerosus and lichen planus.
Matthew Bruno discusses incorporating AI in clinical practice from an administrative and cost savings perspective while implementing an oversight to detect inaccurate information.
Kirk Gautier assesses effective treatment options for patients with cutaneous diseases such as actinic keratosis, squamous cell carcinoma, and basal cell carcinoma.
Dr. Oza discusses the management of various effective treatments for contagiosum, mycoplasma, and measles.
Dr. Abrar Qureshi emphasizes the importance of early diagnosis in hidradenitis suppurativa to improve pain management and drainage outcomes. Topics Covered: Early diagnosis of hidradenitis
Dr. Jennifer Hsiao explores dual biologic therapy as a potential strategy for managing complex, treatment-resistant cases of hidradenitis suppurativa. Topics Covered: Dual biologic use in
Dr. Neal Bhatia reviews promising topical therapies in development, highlighting new mechanisms and formulations shaping the future of dermatologic care. Topics Covered: Emerging topical therapies
Dr. Harper discusses results from head-to-head studies comparing new and existing oral rosacea treatments and navigating the difficulties of treating neurogenic rosacea.
Dr. Liu discusses new and emerging topical therapies for psoriasis and the continued value of topical therapies in psoriasis treatment.
Dr. Andrea Murina discusses how oral therapies can serve as an effective entry point to systemic treatment for patients with psoriasis. Topics Covered: Role of
Dr. Mark Lebwohl outlines key considerations for treating psoriasis in elderly patients, including comorbidities, cancer risk, and treatment affordability. Topics Covered: Psoriasis management in older
Dr. Daveluy discusses an exciting new project to uncover insights into HS disease patterns through analysis with artificial intelligence.
Dr. Elbuluk discusses unique considerations pertaining to inflammatory skin diseases in patients with skin of color.
Dr. Khattri discusses emerging psoriatic arthritis treatments on the horizon, including deucravacitinib, zasocitinib, and icotrokinra.
Dr. James Song reviews how IL-17 inhibitors can be especially effective in treating psoriatic arthritis, special-site psoriasis, and biologic-experienced patients. Topics Covered: IL-17 inhibitors in
Dr. Cohen discusses the best biologics for treating psoriasis of the scalp, intertriginous areas, genitals, nails, and palms and soles of the feet.
Dr. Bhatia reviews exciting new developments in dermatology technology, including a full-body dermoscopic robot, autologous cell transplants for wound healing, and stem cell banking for
Dr. Lio discusses the nuances of approaching patient questions and misconceptions around dietary modifications and restrictions for atopic dermatitis.
Dr. Graber discusses new evidence supporting the use of 1726nm lasers for the treatment of inflammatory and non-inflammatory acne, as well as pulsed-dye laser and
Dr. Daveluy provides tips and guidance for using cryoinsufflation in the treatment of HS.
Dr. Bunick explores the discussion on benzene in benzoyl peroxide (BPO) products, including questions around ensuring products are meeting FDA regulations, what dermatologists can do
Dr. Lio discusses several alternative approaches to managing itch in patients who are being treated for non-dermatologic cancers.
Dr. Daveluy reviews how diet can influence the effectiveness and side effects of certain dermatological drugs.
Dr. Jennifer Hsiao shares emerging strategies for treating recalcitrant hidradenitis suppurativa when standard therapies fail. Topics Covered: Management of treatment-resistant HS Emerging therapies and clinical
Dr. Bunick provides a comprehensive update on using antibiotics for the treatment of acne and rosacea, including influences on gut health, antibiotic resistance, and efficacy
Dr. Swanson discusses the most exciting developments across pediatric atopic dermatitis, psoriasis, alopecia areata, vitiligo, and infantile hemangiomas.
Dr. Chovatiya discusses a symposium that he participated in at AAD 2025 focused on chronic hand eczema, reviewing prevalence, subtypes, morphology, and other important considerations
Dr. Rosmarin highlights his presentation from AAD 2025, in which he reviewed the optimal method for using ruxolitinib cream for vitiligo, touching on setting patient
Dr. Hamzavi reviews the correct patient candidate for surgical therapy for vitiligo and the different options available, including punch grafting, suction blister epidermal grafting, and
Dr. Hamzavi discusses key points from his presentation within the AAD 2025 session on surgical options for hidradenitis suppurativa.
In a summary of one of his talks from AAD 2025, Dr. Drucker discusses the results from a network meta-analysis that provides insight beyond the
Dr. Chovatiya reviews one of his AAD sessions in which he discussed atopic dermatitis, hidradenitis suppurativa, and psoriasis in patients with skin of color. In
Dr. Gooderham discusses JAK inhibition in the context of psoriasis treatment, including comparing the important difference between competitive inhibition and allosteric inhibition when using JAKs
In an overview from his AAD 2025 presentation, Dr. Seneschal reviews important dimensions of the pathogenesis of vitiligo that necessitate maintenance therapy.
Here, Dr. Draelos summarizes the patient-reported outcomes of a recently published study in the March 2025 issue of JCAD,¹ reviewing results from the subject self-assessment
Dr. Valacchi reviews histological findings from a study published in the March 2025 issue of JCAD,¹ which investigated a dietary supplement’s effect on biomarkers of
Dr. Draelos discusses methods and findings of a study published in the March 2025 issue of JCAD,¹ which evaluated the safety and efficacy of a
The third video in The Science of Skin Glycation series features Drs. Zoe Draelos and Giuseppe Valacchi, who discuss research on the potential of rosemary
Drs. Watchmaker and Bucay explore how rosemary extract may help counter glycative stress and improve visible signs of skin aging from the inside out. Topics
In the first of a six-video series exploring glycative stress on the skin, Drs. Jacqueline Watchmaker and Vivian Bucay review the effects of glycation on
Dr. Marghoob discusses how the microanatomy of the face, palms, and nails impacts diagnosing melanomas.
Dr. Song provides an extensive overview of what’s new and emerging in atopic dermatitis treatment. Listen to Dr. Song’s full recap on our JCAD Podcast
Dr. Jenny Murase reviews a decade of insights on safety considerations for dermatologic treatments for pregnant and lactating patients. Topics Covered: Safe dermatologic treatments during
Dr. Murase reviews a decade of insights on safety considerations for dermatologic treatments for pregnant and lactating patients.
Dr. Hawkes discusses the closing gap between biologics and oral treatments for psoriasis and provides an update on a new oral IL-23 receptor inhibitor currently
Dr. Swanson discusses emerging treatments for atopic dermatitis, psoriasis, and alopecia areata in pediatric patients.
Dr. Schlesinger reviews his session presented at the Science of Skincare Summit 2024.
Dr. Nestor reviews his session presented at the Science of Skincare Summit 2024.
Dr. Prithwiraj Maitra discusses the role of biomarker evaluation in skincare research, as presented at the 2024 Science of Skincare Summit in Austin, Texas. Topics
Monica discusses the future of APPs in the rheumatology space and how these clinicians may fill a shortage of rheumatologists in rural areas in the
Rosemary reviews diet choices and supplement considerations for patients with psoriasis and psoriatic arthritis.
Rosemary provides a glimpse at her challenging cases session at the Masterclasses meeting, including lichen planus and cutaneous leishmaniasis in patients with skin of color.
Watch this three-module series with James Del Rosso, DO, who discusses the benefits of semi-occlusive healing ointments over occlusive ointments and petrolatum and their impact on the skin healing process.
Dr. Strober focuses on difficult-to-treat areas in patients with psoriasis and the tremendous impact on quality of life this disease can have.
